NO991551D0 - Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av medikamenter for forebyggelse av emesis og behandling av seksuell dysfunksjon - Google Patents

Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av medikamenter for forebyggelse av emesis og behandling av seksuell dysfunksjon

Info

Publication number
NO991551D0
NO991551D0 NO991551A NO991551A NO991551D0 NO 991551 D0 NO991551 D0 NO 991551D0 NO 991551 A NO991551 A NO 991551A NO 991551 A NO991551 A NO 991551A NO 991551 D0 NO991551 D0 NO 991551D0
Authority
NO
Norway
Prior art keywords
tetrahydrobenz
emesis
carboxamides
indole
drugs
Prior art date
Application number
NO991551A
Other languages
English (en)
Other versions
NO991551L (no
Inventor
Mark Mortensen Foreman
J David Leander
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO991551L publication Critical patent/NO991551L/no
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO991551D0 publication Critical patent/NO991551D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO991551A 1993-06-10 1999-03-30 Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av medikamenter for forebyggelse av emesis og behandling av seksuell dysfunksjon NO991551D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7519893A 1993-06-10 1993-06-10

Publications (2)

Publication Number Publication Date
NO991551L NO991551L (no) 1994-12-12
NO991551D0 true NO991551D0 (no) 1999-03-30

Family

ID=22124191

Family Applications (4)

Application Number Title Priority Date Filing Date
NO19942143A NO321500B1 (no) 1993-06-10 1994-06-09 Anvendelse av et tetrahydrobenz[cd]indol-6-karboksamid for fremstilling av et medikament for behandling av seksuell dysfunksjon
NO991551A NO991551D0 (no) 1993-06-10 1999-03-30 Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av medikamenter for forebyggelse av emesis og behandling av seksuell dysfunksjon
NO993461A NO308693B1 (no) 1993-06-10 1999-07-14 Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider for fremstilling av medikamenter for forebyggelse av emesis
NO20015806A NO20015806D0 (no) 1993-06-10 2001-11-28 Farmasöytisk preparat inneholdende et tetrahydrobenz[c,d]indol-6-karboksamid og anvendelse derav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19942143A NO321500B1 (no) 1993-06-10 1994-06-09 Anvendelse av et tetrahydrobenz[cd]indol-6-karboksamid for fremstilling av et medikament for behandling av seksuell dysfunksjon

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO993461A NO308693B1 (no) 1993-06-10 1999-07-14 Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider for fremstilling av medikamenter for forebyggelse av emesis
NO20015806A NO20015806D0 (no) 1993-06-10 2001-11-28 Farmasöytisk preparat inneholdende et tetrahydrobenz[c,d]indol-6-karboksamid og anvendelse derav

Country Status (17)

Country Link
US (1) US5703112A (no)
EP (2) EP1166783A3 (no)
JP (1) JPH0748254A (no)
KR (2) KR100367792B1 (no)
CN (2) CN1072932C (no)
AU (1) AU677317B2 (no)
CA (1) CA2125088A1 (no)
CZ (2) CZ285762B6 (no)
HK (1) HK1043322B (no)
HU (1) HUT71464A (no)
IL (1) IL109872A (no)
NO (4) NO321500B1 (no)
NZ (2) NZ260667A (no)
RU (1) RU2154476C2 (no)
TW (1) TW258660B (no)
UA (2) UA29415C2 (no)
ZA (1) ZA943862B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4663100A (en) 1999-04-30 2000-11-17 Lilly Icos Llc Treatment of female arousal disorder
GB0106446D0 (en) * 2001-03-15 2001-05-02 Vernalis Res Ltd Chemical compounds
AU2006254899B2 (en) 2005-06-08 2011-11-24 Sk Biopharmaceuticals Co., Ltd. Treatment of sleep-wake disorders
CA2612672C (en) * 2005-06-22 2014-10-14 Janssen Pharmaceutica, N.V. Treatment for sexual dysfunction
US8741950B2 (en) 2009-06-22 2014-06-03 Sk Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
MX2012005258A (es) 2009-11-06 2012-06-19 Sk Biopharmaceuticals Co Ltd El uso de un compuesto de carbamoilo para el tratamiento del trastorno de deficit de atencion/hiperactividad.
AU2010316172B2 (en) 2009-11-06 2015-11-12 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
DK2968208T3 (da) 2013-03-13 2022-08-22 Jazz Pharmaceuticals Ireland Ltd Behandling af kataplexi
CN110638804A (zh) 2013-07-18 2020-01-03 爵士制药国际Iii有限公司 治疗肥胖
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR20200016889A (ko) 2017-06-02 2020-02-17 재즈 파마슈티칼즈 아일랜드 리미티드 과다 졸림증을 치료하기 위한 방법 및 조성물
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
US4943428A (en) * 1987-07-10 1990-07-24 Wright State University Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
KR0151699B1 (ko) * 1989-07-13 1998-10-15 로버트 에이. 아미테이지 (1,2n) 및 (3,2n)-카보사이클릭-2-아미노테트랄린 유도체
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
WO1991013872A1 (en) * 1990-03-15 1991-09-19 The Upjohn Company Therapeutically useful heterocyclic indole compounds
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof

Also Published As

Publication number Publication date
NO20015806L (no) 1994-12-12
CN1072932C (zh) 2001-10-17
KR950000146A (ko) 1995-01-03
CZ285829B6 (cs) 1999-11-17
EP0633023A2 (en) 1995-01-11
UA37311C2 (uk) 2001-05-15
NO991551L (no) 1994-12-12
HU9401730D0 (en) 1994-09-28
RU94020717A (ru) 1996-08-27
CZ135494A3 (en) 1994-12-15
CN1342457A (zh) 2002-04-03
RU2154476C2 (ru) 2000-08-20
ZA943862B (en) 1995-12-04
JPH0748254A (ja) 1995-02-21
EP1166783A3 (en) 2002-01-09
IL109872A0 (en) 1994-10-07
NO308693B1 (no) 2000-10-16
NO321500B1 (no) 2006-05-15
NO20015806D0 (no) 2001-11-28
AU6460794A (en) 1994-12-15
CN1170536C (zh) 2004-10-13
CZ285762B6 (cs) 1999-11-17
EP1166783A2 (en) 2002-01-02
IL109872A (en) 2000-12-06
NZ314570A (en) 2000-11-24
US5703112A (en) 1997-12-30
HK1043322A1 (en) 2002-09-13
AU677317B2 (en) 1997-04-17
NO942143L (no) 1994-12-12
EP0633023A3 (en) 1995-03-29
NZ260667A (en) 1997-05-26
HUT71464A (en) 1995-11-28
KR100367792B1 (ko) 2003-02-19
KR100367791B1 (ko) 2003-02-14
NO993461D0 (no) 1999-07-14
CN1100634A (zh) 1995-03-29
NO942143D0 (no) 1994-06-09
HK1043322B (zh) 2005-06-03
TW258660B (no) 1995-10-01
UA29415C2 (uk) 2000-11-15
NO993461L (no) 1994-12-12
CA2125088A1 (en) 1994-12-11

Similar Documents

Publication Publication Date Title
NO974808D0 (no) Styrt frigivelse av legemidler for miose og mydriase i fremre kammer
NO944164D0 (no) Fremgangsmåte for fremstilling og anvendelse av en HCl-adsorbent
CY2006007I2 (el) Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας
NO962179L (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
DE69521799D1 (de) Polymer umhüllte tablette enthaltend amoxicillin und clavulanat
NO894409D0 (no) Fremgangsmaate og innretning for avretting av avmantlede ender i rundkabler.
BR9406209A (pt) Derivados heterociclicos no tratamento de isquemia e doenças relacionadas
NO991551D0 (no) Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av medikamenter for forebyggelse av emesis og behandling av seksuell dysfunksjon
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
EP0626174A3 (en) Method and composition for the prophylaxis and / or treatment of underactive organs.
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
DE69624243D1 (de) Verwendung von unverdaulichen oligosacchariden zur vorbeugung und behandlung von mittelohrentzündung bei menschen
NO982727D0 (no) PGE-holdige lyofiliserte liposomer for anvendelse i behandling av erektil dysfunksjon
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO961226L (no) Blandinger for forebyggelse og behandling av viralinduserte tumorer
NO933477L (no) 6-heterosyklisk-4-amino-1,3,4,5-tetrahydrobenz(cd)indoler for behandling av reisesyke og oppkast
TW282455B (no)
HUP0003244A3 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases and pharmaceutical compositions thereof
NO984572L (no) Anvendelse av 2,5-dihydroksybenzensulfonderivater for fremstilling av legemidler ment for normalisering av den endoteliale funksjon, for behandling av seksuell dysfunksjon og vaskulµre komplikasjoner i diabetes, sÕvel som vaskulµre lidelser av e
SG46724A1 (en) Use of granisetron for the treatment of post operative nausea and vomittung
ZA88922B (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
NO950248D0 (no) NG-monometyl-L-argininhydrokloridderivater og anvendelse derav for behandling av septisk sjokk
AU2164992A (en) Process and device for the continuous treatment of silicon
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders